Pharmaceuticals - LG/Merck in deal to make off-patent drugs

被引：0
作者：
不详
机构：
来源：
EUROPEAN CHEMICAL NEWS | 1997年 / 68卷 / 1780期
关键词：
D O I：
暂无
中图分类号：
TQ [化学工业];
学科分类号：
0817 ;
摘要：
引用
收藏
页码：4 / 4
页数：1
相关论文
共 50 条
  • [1] Role of the FDA in Affordability of Off-Patent Pharmaceuticals
    Greene, Jeremy A.
    Anderson, Gerard
    Sharfstein, Joshua M.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2016, 315 (05): : 461 - 462
  • [2] EXCESSIVE PRICING OF OFF-PATENT PHARMACEUTICALS: HATCH IT OR RATCHET?
    Graber, Jennifer L.
    NEW YORK UNIVERSITY LAW REVIEW, 2017, 92 (04) : 1146 - 1186
  • [3] Not everyone is perfect: About off-patent drugs
    不详
    ANNALS OF ONCOLOGY, 2001, 12 (06) : 728 - 728
  • [4] The Economics of Pediatric Formulation Development for Off-Patent Drugs
    Milne, Christopher-Paul
    Bruss, Jon B.
    CLINICAL THERAPEUTICS, 2008, 30 (11) : 2133 - 2145
  • [5] Challenges in conducting paediatric trials with off-patent drugs
    Haslund-Krog, S. S.
    Jorgensen, I. M.
    Henriksen, T. B.
    Dalhoff, K.
    Debes, N. M.
    van den Anker, J.
    Holst, H.
    CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS, 2021, 23
  • [6] Off-patent drugs in Italy: A short-sighted view?
    Garattini L.
    Ghislandi S.
    The European Journal of Health Economics, 2006, 7 (1) : 79 - 83
  • [7] Senate Committee Investigates Price Hikes for Off-Patent Drugs
    Rubin, Rita
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2016, 315 (06): : 549 - 549
  • [8] Federal Spending on Off-Patent Drugs That Lack Generic Competition
    Rome, Benjamin N.
    Kesselheim, Aaron S.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2021, 36 (03) : 821 - 823
  • [9] Federal Spending on Off-Patent Drugs That Lack Generic Competition
    Benjamin N. Rome
    Aaron S. Kesselheim
    Journal of General Internal Medicine, 2021, 36 : 821 - 823
  • [10] Nifedipine labeling illustrates the pediatric dilemma for off-patent drugs
    Adcock, KG
    Wilson, JT
    PEDIATRICS, 2002, 109 (02) : 319 - 321
12345